Clinical trial
Study Of White Blood Cells In The Cerebrospinal Fluid And Blood Of Patients With…
NCT00469378 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00469378 |
|---|---|
| Title | Study Of White Blood Cells In The Cerebrospinal Fluid And Blood Of Patients With Relapsing Forms Of Multiple Sclerosis |
| Official title | An Open-label Study of Leukocyte Counts in the Cerebrospinal Fluid and Blood of Subjects With Relapsing Forms of Multiple Sclerosis Following Treatment With Firategrast |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | firategrast |
| Enrollment | 46 |
| Start date | Jul 1, 2007 |
| Primary completion | May 1, 2009 |
| Completion | Feb 1, 2010 |
| First posted | May 4, 2007 |
| Last update posted | Mar 23, 2017 |
| Countries | Belgium, Czechia, Denmark, Norway, Sweden |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: